LifeMD expands access to Lilly’s self-pay GLP-1 medicines, enabling option to dispense and ship directly to patients nationwide
LifeMD announced an arrangement with Eli Lilly enabling its affiliated pharmacy to directly dispense and ship Lilly's self-pay GLP-1 medicines, Zepbound and Foundayo, to eligible patients nationwide. Prescriptions from LifeMD-affiliated providers are fulfilled by LifeMD's licensed mail-order pharmacy at Lilly's established self-pay cash price, with no insurance billing.
Key figures
- Geographic coverage
- nationwide (50 states)
- Medications included
- ["Zepbound (tirzepatide)","Foundayo (orforglipron)"]
AI analysis
Red flags2 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.